Thursday, Oct 22, 2026
Focus on the big picture

BVTV: Obesity boom

Reuters, 28 Nov 2022
From @Breakingviews: Novo Nordisk and Eli Lilly’s valuations have ballooned thanks to their weight loss drugs. Rivals like Pfizer and AstraZeneca may muscle in and grab a slice of the market that could be worth $50 billion by 2030, @aimeedonnellan says.

#News #Reuters #newsfeed

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Related Articles